These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 11208117)

  • 1. Human cytomegalovirus immediate early glycoprotein US3 retains MHC class I molecules by transient association.
    Gruhler A; Peterson PA; Früh K
    Traffic; 2000 Apr; 1(4):318-25. PubMed ID: 11208117
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural and functional dissection of human cytomegalovirus US3 in binding major histocompatibility complex class I molecules.
    Lee S; Yoon J; Park B; Jun Y; Jin M; Sung HC; Kim IH; Kang S; Choi EJ; Ahn BY; Ahn K
    J Virol; 2000 Dec; 74(23):11262-9. PubMed ID: 11070025
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of HLA-DR assembly, transport, and loading by human cytomegalovirus glycoprotein US3: a novel mechanism for evading major histocompatibility complex class II antigen presentation.
    Hegde NR; Tomazin RA; Wisner TW; Dunn C; Boname JM; Lewinsohn DM; Johnson DC
    J Virol; 2002 Nov; 76(21):10929-41. PubMed ID: 12368336
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human cytomegalovirus inhibits antigen presentation by a sequential multistep process.
    Ahn K; Angulo A; Ghazal P; Peterson PA; Yang Y; Früh K
    Proc Natl Acad Sci U S A; 1996 Oct; 93(20):10990-5. PubMed ID: 8855296
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of the MHC class II antigen presentation pathway by human cytomegalovirus.
    Johnson DC; Hegde NR
    Curr Top Microbiol Immunol; 2002; 269():101-15. PubMed ID: 12224504
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determinant for endoplasmic reticulum retention in the luminal domain of the human cytomegalovirus US3 glycoprotein.
    Lee S; Park B; Ahn K
    J Virol; 2003 Feb; 77(3):2147-56. PubMed ID: 12525649
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human cytomegalovirus US3 chimeras containing US2 cytosolic residues acquire major histocompatibility class I and II protein degradation properties.
    Chevalier MS; Johnson DC
    J Virol; 2003 Apr; 77(8):4731-8. PubMed ID: 12663780
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human cytomegalovirus US3 impairs transport and maturation of major histocompatibility complex class I heavy chains.
    Jones TR; Wiertz EJ; Sun L; Fish KN; Nelson JA; Ploegh HL
    Proc Natl Acad Sci U S A; 1996 Oct; 93(21):11327-33. PubMed ID: 8876135
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural and functional analysis of human cytomegalovirus US3 protein.
    Misaghi S; Sun ZY; Stern P; Gaudet R; Wagner G; Ploegh H
    J Virol; 2004 Jan; 78(1):413-23. PubMed ID: 14671122
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Binding of human cytomegalovirus US2 to major histocompatibility complex class I and II proteins is not sufficient for their degradation.
    Chevalier MS; Daniels GM; Johnson DC
    J Virol; 2002 Aug; 76(16):8265-75. PubMed ID: 12134032
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human cytomegalovirus inhibits tapasin-dependent peptide loading and optimization of the MHC class I peptide cargo for immune evasion.
    Park B; Kim Y; Shin J; Lee S; Cho K; Früh K; Lee S; Ahn K
    Immunity; 2004 Jan; 20(1):71-85. PubMed ID: 14738766
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A short isoform of human cytomegalovirus US3 functions as a dominant negative inhibitor of the full-length form.
    Shin J; Park B; Lee S; Kim Y; Biegalke BJ; Kang S; Ahn K
    J Virol; 2006 Jun; 80(11):5397-404. PubMed ID: 16699020
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Placental extravillous cytotrophoblasts persistently express class I major histocompatibility complex molecules after human cytomegalovirus infection.
    Terauchi M; Koi H; Hayano C; Toyama-Sorimachi N; Karasuyama H; Yamanashi Y; Aso T; Shirakata M
    J Virol; 2003 Aug; 77(15):8187-95. PubMed ID: 12857887
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional analysis of the human cytomegalovirus immune evasion protein, pUS3(22kDa).
    Zhao Y; Biegalke BJ
    Virology; 2003 Oct; 315(2):353-61. PubMed ID: 14585338
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Varicella-zoster virus retains major histocompatibility complex class I proteins in the Golgi compartment of infected cells.
    Abendroth A; Lin I; Slobedman B; Ploegh H; Arvin AM
    J Virol; 2001 May; 75(10):4878-88. PubMed ID: 11312359
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of human cytomegalovirus US3 gene products.
    Liu W; Zhao Y; Biegalke B
    Virology; 2002 Sep; 301(1):32-42. PubMed ID: 12359444
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human cytomegalovirus-encoded immune modulators partner to downregulate major histocompatibility complex class I molecules.
    Noriega VM; Tortorella D
    J Virol; 2009 Feb; 83(3):1359-67. PubMed ID: 19004944
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MHC class II presentation of endogenous tumor antigen by cellular vaccines depends on the endocytic pathway but not H2-M.
    Qi L; Ostrand-Rosenberg S
    Traffic; 2000 Feb; 1(2):152-60. PubMed ID: 11208095
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Control of MHC class I traffic from the endoplasmic reticulum by cellular chaperones and viral anti-chaperones.
    Gruhler A; Früh K
    Traffic; 2000 Apr; 1(4):306-11. PubMed ID: 11208115
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rhesus cytomegalovirus contains functional homologues of US2, US3, US6, and US11.
    Pande NT; Powers C; Ahn K; Früh K
    J Virol; 2005 May; 79(9):5786-98. PubMed ID: 15827193
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.